+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Live Attenuated Vaccine"

From
From
From
Pediatric Vaccine Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Pediatric Vaccine Market - Forecasts from 2024 to 2029

  • Report
  • May 2024
  • 130 Pages
  • Global
From
From
From
Human Combination Vaccines Market 2024-2028 - Product Thumbnail Image

Human Combination Vaccines Market 2024-2028

  • Report
  • May 2024
  • 176 Pages
  • Global
From
From
From
From
From
From
From
Asia Pacific Vaccine Market Report and Forecast 2024-2032 - Product Thumbnail Image

Asia Pacific Vaccine Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 180 Pages
  • Asia Pacific
From
Vaccine Contract Manufacturing Market Report 2023-2033 - Product Thumbnail Image

Vaccine Contract Manufacturing Market Report 2023-2033

  • Report
  • May 2023
  • 375 Pages
  • Global
From
Nasal Vaccines: Global Markets and Pipeline Analysis - Product Thumbnail Image

Nasal Vaccines: Global Markets and Pipeline Analysis

  • Report
  • December 2022
  • 78 Pages
  • Global
From
Loading Indicator

Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus. Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines. Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more